KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.verified

KALV

Price:

$27

Market Cap:

$1.44B

KalVista Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical firm dedicated to the discovery, development, and commercialization of small molecule protease inhibitors. These inhibitors aim to address diseases with significant unmet medical needs. The company's core therapeutic strategy centers on its pipeline of small molecule plasma kallikrein inhibitors. These are specifically engineered to combat debilitating conditions such as hereditary angioedema (HAE) and diabetic macular edema (DME), with several formulated as oral treatments. Key products in their portfolio include: KVD001, a plasma kallikrein inhibitor that has successfully concluded a Phase II clinical trial for the ...[Read more]

Industry

Biotechnology

IPO Date

2015-04-09

Stock Exchange

NASDAQ

Ticker

KALV

The ROE as of June 2026 (TTM) for KalVista Pharmaceuticals, Inc. (KALV) is -1057.44%

According to KalVista Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -1057.44%. This represents a change of -775.57% compared to the average of 156.52% of the last 4 quarters.

KalVista Pharmaceuticals, Inc. (KALV) Historical ROE (quarterly & annually)

How has KALV ROE performed in the past?

The mean historical ROE of KalVista Pharmaceuticals, Inc. over the last ten years is 551.25%. The current -1057.44% ROE has changed -291.82% with respect to the historical average. Over the past ten years (40 quarters), KALV's ROE was at its highest in in the December 2025 quarter at 866.36%. The ROE was at its lowest in in the October 2025 quarter at -291.09%.

Quarterly (TTM)
Annual

Average

551.25%

Median

-51.09%

Minimum

-192.31%

Maximum

6.06%

KalVista Pharmaceuticals, Inc. (KALV) ROE by Quarter and Year

Discovering the peaks and valleys of KalVista Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 213.69%

Maximum Annual ROE = 6.06%

Minimum Annual Increase = -3251.19%

Minimum Annual ROE = -192.31%

Quarterly (TTM)
Annual
YearROEChange
20256.06%-3251.19%
2025-192.31%213.69%
2024-61.30%6.25%
2023-57.70%29.70%
2022-44.49%147.41%
2021-17.98%-48.28%
2020-34.76%61.56%
2019-21.52%-62.90%
2018-57.99%-2.34%
2017-59.38%11.62%

KalVista Pharmaceuticals, Inc. (KALV) Average ROE

How has KALV ROE performed in the past?

The current ROE of KalVista Pharmaceuticals, Inc. (KALV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.94%

5-year avg

1.14%

10-year avg

551.25%

KalVista Pharmaceuticals, Inc. (KALV) ROE vs. Peers

How is KALV’s ROE compared to its peers?

KalVista Pharmaceuticals, Inc.’s ROE is less than Gossamer Bio, Inc. (174.85%), greater than 4D Molecular Therapeutics, Inc. (-36.83%), greater than Prothena Corporation plc (-49.88%), greater than Bicycle Therapeutics plc (-35.74%), greater than Omeros Corporation (-54.39%), greater than Verastem, Inc. (-486.41%), less than Rigel Pharmaceuticals, Inc. (147.03%), greater than Olema Pharmaceuticals, Inc. (-45.95%), less than ADC Therapeutics S.A. (65.27%), greater than RAPT Therapeutics, Inc. (-61.81%),

Build a custom stock screener for KalVista Pharmaceuticals, Inc. (KALV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KalVista Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

KalVista Pharmaceuticals, Inc. (KALV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like KalVista Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is KalVista Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for KalVista Pharmaceuticals, Inc. (KALV)?

What is the highest ROE for KalVista Pharmaceuticals, Inc. (KALV)?

What is the 3-year average ROE for KalVista Pharmaceuticals, Inc. (KALV)?

What is the 5-year average ROE for KalVista Pharmaceuticals, Inc. (KALV)?

How does the current ROE for KalVista Pharmaceuticals, Inc. (KALV) compare to its historical average?